Abbvie Inc (ABBV)

[stocktrademan]

$ABBV recent news/filings

bullish

## source: finance.yahoo.com

Thu, 04 Jun 2015 15:58:00 GMT ~ 2015 Global 2000: The World's Largest Drug And Biotech Companies


read full: http://www.forbes.com/sites/liyanchen/2015/06/04/2015-global-2000-the-worlds-largest-drug-and-biotech-companies/?utm_campaign=yahootix&partner=yahootix
*********************************************************

Thu, 04 Jun 2015 14:05:00 GMT ~ 10:05 am AbbVie shares +1% after announcing improved progression-free survival and multiple secondary endpoints for ibrutinib in the final analysis of the Phase III RESONATE-2 trial


read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#abbv
*********************************************************

Thu, 04 Jun 2015 13:50:01 GMT ~ Halozyme-AbbVie Ink Deal for ENHANZE Platform, Shares Up - Analyst Blog


read full: http://finance.yahoo.com/news/halozyme-abbvie-ink-deal-enhanze-135001781.html
*********************************************************

Thu, 04 Jun 2015 13:20:00 GMT ~ Ibrutinib (IMBRUVICA®) Improved Survival for Treatment-Naive Chronic Lymphocytic Leukemia Patients in Phase III RESONATE™-2 Trial

[PR Newswire] - RESONATE-2 is a randomized, multi-center, open-label study assessing the use of ibrutinib versus chlorambucil in treatment-naïve CLL/SLL patients aged 65 years or older. IMBRUVICA is jointly developed and commercialized by Pharmacyclics and Janssen Biotech, Inc. "In collaboration with our partner Janssen, we are very excited by the findings from RESONATE-2 and look forward to sharing the results from what we see as a potentially transformative study for CLL patients," said Danelle James, M.D., M.S., Head of Oncology at Pharmacyclics.

read full: http://finance.yahoo.com/news/ibrutinib-imbruvica-improved-survival-treatment-132000678.html
*********************************************************

Thu, 04 Jun 2015 11:11:04 GMT ~ AbbVie's Research in Immunology to be Featured at the European League Against Rheumatism Annual Congress (EULAR) 2015

[at noodls] - - More than 20 abstracts evaluate HUMIRA in approved indications and non-infectious intermediate, posterior, or panuveitis, an investigational indication for HUMIRA - Data evaluating four investigational ...

read full: http://www.noodls.com/view/F520A23A0AEE1EEC1509B2193ED2F666B4C14522
*********************************************************

$ABBV charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$ABBV company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ABBV/company-info
Ticker: $ABBV
OTC Market Place: Not Available
CIK code: not found
Company name: AbbVie Inc.
Incorporated In:

Business Description:

$ABBV share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$ABBV extra dd links

Company name: AbbVie Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ABBV+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ABBV+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ABBV+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ABBV/news - http://finance.yahoo.com/q/h?s=ABBV+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ABBV/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ABBV/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ABBV+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ABBV
DTCC (dtcc.com): http://search2.dtcc.com/?q=AbbVie+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=AbbVie+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=AbbVie+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ABBV
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ABBV/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ABBV/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ABBV&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ABBV
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ABBV/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ABBV+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ABBV+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ABBV
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ABBV
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ABBV+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ABBV/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ABBV+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ABBV.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ABBV
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ABBV/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ABBV/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ABBV
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ABBV
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ABBV:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ABBV
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ABBV



$ABBV DD Notes ~ http://www.ddnotesmaker.com/ABBV